Purchase Order N6809515P3009
Award Date 10/1/15
Potential Completion Date 9/30/16
Potential Value $38K
Federal Agency
Awardee
Ultimate Awardee
NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Valencia, CA 91355, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price purchase order awarded by the Defense Health Agency to Qiagen, LLC, a division of the international diagnostics company Qiagen N.V. The contract, valued at $14,480.01, is for the FMRT-1-25-US AMNISURE ROM TEST. The award does not indicate any set-aside designation. Qiagen has previously provided a range of products and services to support federal biomedical research, public health, law enforcement, and healthcare programs under prime and subcontracts with agencies such...
- The Defense Health Agency awarded a $39,540 firm fixed-price purchase order to Qiagen, LLC on October 1, 2023, under the AMNISURE ROM TEST #FMRT-1-25-US contract for performance through September 30, 2026. This represents a Fiscal Year 2026 funding modification for option year two, with no small business set-aside designation applied. Qiagen, a foreign-owned molecular diagnostics manufacturer headquartered in Germantown, Maryland, will perform work at Fort Johnson South, Louisiana. The company...
- The U.S. Defense Health Agency awarded a Firm Fixed Price purchase order contract to Qiagen, LLC, a division of the parent company Qiagen N.V., for the FMRT-1-25-US AMNISURE ROM TEST. The $16,684.86 contract has an ultimate completion date of April 15, 2016. Qiagen is an international provider of sample and assay technologies for molecular diagnostics, applied testing, pharma, and academics, and has delivered a range of products and services to federal agencies through past prime and...
- This is a firm fixed-price purchase order contract awarded by the Defense Health Agency (DHA) to Qiagen, LLC, a division of the international biotechnology company Qiagen N.V. The contract, valued at $92,270.00, is for the FMRT-1-25-US ROM TEST requirement and has an ultimate completion date of February 28, 2022. Qiagen, which has provided a range of products and services to federal agencies in the past, will deliver equipment, reagents, and testing services to support the DHA's biomedical...
- This federal contract award was issued by the Bureau of Medicine and Surgery, a component of the U.S. Department of Defense, to Qiagen, LLC, a subsidiary of the biotechnology company Qiagen N.V. The $1,897 firm fixed-price purchase order is for labor hours (CLIN 9236439) with a period of performance through September 29, 2019. Qiagen is an established provider of sample and assay technologies supporting federal agencies' biomedical research, public health, law enforcement, and healthcare...
- The Department of the Navy Bureau of Medicine and Surgery awarded a firm-fixed-price purchase order contract to Qiagen, LLC, a division of Qiagen N.V., an international provider of sample and assay technologies. The $5,356 contract has a period of performance through April 11, 2025 and does not have a set-aside designation. Qiagen is a manufacturer of goods and has provided a range of products and services to support federal agencies' biomedical research, public health, law enforcement, and...
- This is a firm fixed-price purchase order awarded by the U.S. Navy Bureau of Medicine and Surgery to Qiagen, LLC, a division of the international diagnostics company Qiagen N.V. The $10,546.00 contract is for QIAXTRACTOR/QIACUBE HT SERVICE, which are likely equipment maintenance and service support for Qiagen's sample processing and diagnostic systems used in federal biomedical research, public health, and healthcare programs. Qiagen has a history of providing a range of products and services to...
- This is a $97,350.04 firm fixed-price purchase order awarded by the Defense Health Agency to Qiagen, LLC, a subsidiary of the biotechnology company Qiagen N.V. The contract is for QIAGEN EQUIPMENT MAINTENANCE SERVICES and has a period of performance through September 28, 2024. No set-aside designation was used. Qiagen is a major provider of sample and assay technologies to federal agencies, supporting programs related to biomedical research, public health, law enforcement, and healthcare. This...
- This is a $90,102.48 firm fixed-price delivery order awarded by the Bureau of Medicine and Surgery, a defense agency, to Qiagen, LLC. The contract is for "QFT REFERENCE LAB PACK, TB LAB TEST SUPPLIES" under Qiagen's existing General Services Administration (GSA) Federal Supply Schedule contract for in vitro diagnostics, reagents, and tests. The contract has an ultimate completion date of June 1, 2018 and does not have a set-aside designation. Qiagen is an international provider of...
- This is a $211,853.58 firm fixed-price purchase order awarded by the Defense Health Agency to Qiagen, LLC, a foreign-owned, for-profit manufacturer of molecular diagnostics, laboratory equipment, and bioinformatics software. The contract is for QCII ONE PRECUR 301-600 TESTING, with a period of performance through May 31, 2027. Qiagen, LLC is a subsidiary of the multinational biotechnology company Qiagen N.V., which has a significant federal contract portfolio supporting biomedical research,...